<<

Drugs with QT Prolonging Effects (Categorized into TdP Risk)

Drugs to Avoid in Congenital Long QT (Known Risk of TdP) Risk Level Physical Health Behavioral Health Anesthetic: , , , : , droperidol, Antiarrhythmic: , disopyramide, , , dronedarone, dofetilide, flecainide, ibutilide, procainamide, , SSRI: , Anticancer: arsenic, vandetanib, oxaliplatin

Antimalarial: chloroquine

PDE3 inhibitor: anagrelide, cilostazol

Known Risk of TdP ABX: azithromycin, chloroquine, ciprofloxacin, clarithromycin, , levofloxacin, moxifloxacin

Cholinesterase Inhibitor: donepezil

Antifungal: fluconazole, pentamidine

Opioids:

Antiemetic: , droperidol

Vasodilator: papaverine

Disclaimer: this is not an all-inclusive list. Please refer to crediblemeds.org for full listing with updates Mercy Care Clinical Pharmacy Services, December 2018

Drugs to Avoid in Congenital Long QT (Possible Risk of TdP) Risk Level Physical Health Behavioral Health Alpha 1 blocker: Antipsychotics: , , , DA : , , , HIV: , lopinavir+, rilpivirine, saquinavir /psychotic: Anticancer: apalutamide, bendamustine, bortezomib, bosutinib, cabozantinib, capectabine, certinib, crizotinib, dabrafenib, dasatinib, degarelix, encorafenib, epirubicin, eribulin, fluorouracil, Antimania: Lithium inotuzumab, lapatinib, leuprolide, lenvatinib, midostaurin, necitumumab, nilotinib, osimertinib, panobinostat, pazopanib, ADHD: romidepsin, ribociclib, sorafenib, sunitinib, tamoxifen, tipiracil + trifluridine, toremifene, vemurafenib, vorinostat TCA: , , , Immunosuppressant: ,

Antiemetic: , , SNRI:

Somatostatin analog: pasireotide Tetracyclic anti-: , : buprenorphine, hydrocodone ER, Possible Risk of TdP :

Anticonvulsant: ezogabine, felbamate,

NMDA receptor antagonist:

ABX: bedaquiline, gemifloxacin, ofloxacin, telavancin,telithromycin

Antimalaria: artemether + lumefantrine, primaquine

Bladder: ,

Muscle relaxant:

Antihypertensive: isradipine, moexipril/HCTZ ,

Anticoagulant: betrixaban

PDE5 inhibitor: vardenafil

Vesicular 2 inhibitor: deutrabenazine, , Disclaimer: this is not an all-inclusive list. Please refer to crediblemeds.org for full listing with updates Mercy Care Clinical Pharmacy Services, December 2018

Drugs to Avoid in Congenital Long QT (Conditional Risk of TdP) Risk Level Physical Health Behavioral Health DA agonist: : , , : amphotericin B, itraconazole, , posaconazole, voriconazole TCA: ,

HIV: atazanavir, nelfinavir, ritonavir SSRI: , , , ABX: metronidazole, piperacillin/tazobactam SARI: Antiarrhythmic:

Antiemetic:

Antihistamine: ,

Antacid:

H2-receptor antagonist:

PPI: Esomeprazole, lansoprazole, pantoprazole, Conditional Risk of TdP : , , , torsemide, , Bendroflumethiazide or bendrofluazide

Cholinesterase Inhibitor:

Anti-inflammatory: hydroxychloroquine

Anti-diarrheal: loperamide

Anti-anginal: ranolazine, ivabradine

Hepatitis C: telapravir

Anti-malarial: quinine, hydroxychloroquine

Muscle relaxant:

Sedative:

Disclaimer: this is not an all-inclusive list. Please refer to crediblemeds.org for full listing with updates Mercy Care Clinical Pharmacy Services, December 2018

Drugs to Avoid in Congenital Long QT (not associated with TdP) Risk Level Physical Health Behavioral Health Vasoconstrictor: , , ADHD: , , epinephrine , , Inotrope: , , , Decongestant:

Bronchodilator: albuterol, , , Drugs to Avoid in , isoproterenol, levalbuterol, olodaterol, Congenital Long QT , , metaproterenol, /fluticasone,

Hypotension:

Obesity agents: ,

ABX: trimethoprim-sulfamethoxazole

Reference: Pharmacist’s Letter and Credible Meds

Disclaimer: this is not an all-inclusive list. Please refer to crediblemeds.org for full listing with updates Mercy Care Clinical Pharmacy Services, December 2018